X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6638) 6638
Book Review (685) 685
Publication (338) 338
Newsletter (77) 77
Book / eBook (42) 42
Book Chapter (26) 26
Conference Proceeding (4) 4
Magazine Article (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6095) 6095
animals (4359) 4359
humans (2600) 2600
male (2141) 2141
female (2135) 2135
rats (1554) 1554
pharmacology & pharmacy (1103) 1103
prostaglandins (1044) 1044
mice (900) 900
prostaglandins f, synthetic - pharmacology (824) 824
in vitro techniques (820) 820
dose-response relationship, drug (681) 681
pregnancy (672) 672
prostaglandin endoperoxides, synthetic - pharmacology (648) 648
inflammation (605) 605
cells, cultured (597) 597
biochemistry & molecular biology (584) 584
15-hydroxy-11 alpha,9 alpha-prosta-5,13-dienoic acid (522) 522
indomethacin - pharmacology (510) 510
rabbits (435) 435
abridged index medicus (429) 429
prostaglandins - pharmacology (429) 429
adult (419) 419
physiology (416) 416
ophthalmology (404) 404
expression (398) 398
time factors (397) 397
cell biology (384) 384
prostaglandin (384) 384
prostaglandins e - pharmacology (372) 372
cyclooxygenase-2 (369) 369
prostaglandin-endoperoxide synthases - metabolism (369) 369
middle aged (358) 358
intraocular pressure - drug effects (352) 352
arachidonic acid (351) 351
inhibition (342) 342
prostaglandins - biosynthesis (332) 332
prostaglandins e, synthetic - pharmacology (329) 329
prostaglandins f - pharmacology (327) 327
nitric oxide (326) 326
dogs (305) 305
cells (304) 304
physiological aspects (303) 303
research (301) 301
analysis (296) 296
rats, inbred strains (296) 296
rats, sprague-dawley (296) 296
endocrinology & metabolism (293) 293
glaucoma (283) 283
cyclooxygenase inhibitors - pharmacology (279) 279
guinea pigs (278) 278
kinetics (277) 277
platelet aggregation - drug effects (276) 276
rodents (275) 275
cell line (273) 273
muscle contraction - drug effects (273) 273
prostaglandin e2 (271) 271
rats, wistar (271) 271
proteins (269) 269
thromboxane a2 - pharmacology (268) 268
dinoprostone - pharmacology (262) 262
activation (260) 260
dinoprostone - metabolism (258) 258
aged (257) 257
dinoprostone (256) 256
immunology (255) 255
prostaglandins - metabolism (254) 254
cyclooxygenase 2 (251) 251
prostaglandin e (251) 251
cattle (248) 248
thromboxane a2 - analogs & derivatives (245) 245
epoprostenol - pharmacology (241) 241
in-vitro (240) 240
latanoprost (239) 239
prostaglandin e-2 (239) 239
prostaglandins f, synthetic - administration & dosage (239) 239
prostaglandins, synthetic - pharmacology (239) 239
lipids (235) 235
neurosciences (233) 233
medicine (230) 230
nitric-oxide (228) 228
research article (228) 228
blood pressure - drug effects (226) 226
pharmacology (224) 224
chemistry, medicinal (223) 223
cytokines (223) 223
enzymes (223) 223
prostaglandin endoperoxide synthase (221) 221
structure-activity relationship (221) 221
signal transduction (220) 220
cyclooxygenase 2 - metabolism (217) 217
gene expression (217) 217
prostaglandins - physiology (216) 216
dinoprost - pharmacology (214) 214
cyclooxygenase (213) 213
cox-2 inhibitors (212) 212
vasoconstrictor agents - pharmacology (212) 212
receptors (210) 210
prostaglandins f, synthetic - therapeutic use (207) 207
disease models, animal (206) 206
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6598) 6598
Russian (41) 41
German (39) 39
Italian (18) 18
Japanese (16) 16
Slovak (14) 14
Chinese (13) 13
Polish (12) 12
French (8) 8
Spanish (8) 8
Bulgarian (6) 6
Romanian (4) 4
Czech (3) 3
Dutch (3) 3
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 02/2015, Volume 749, pp. 73 - 80
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0158797 - e0158797
Purpose To compare the safety and efficacy of fixed-dose tafluprost/timolol combination (Taf/T-FDC) with those of fixed-dose latanoprost/timolol combination... 
MEDICATION | OPHTHALMIC SOLUTION | OPEN-ANGLE GLAUCOMA | MULTICENTER | MULTIDISCIPLINARY SCIENCES | OCULAR HYPERTENSION | INDIVIDUAL COMPONENTS | INTRAOCULAR-PRESSURE | TIMOLOL | ADHERENCE | BIOAVAILABILITY | Antihypertensive Agents - pharmacology | Intraocular Pressure - drug effects | Area Under Curve | Ocular Hypertension - physiopathology | Humans | Macaca fascicularis | Male | Metabolic Clearance Rate | Ocular Hypertension - metabolism | Ocular Hypertension - drug therapy | Tandem Mass Spectrometry | Timolol - pharmacokinetics | Time Factors | Prostaglandins F - pharmacology | Chromatography, Liquid | Prostaglandins F - pharmacokinetics | Female | Glaucoma - metabolism | Prostaglandins F, Synthetic - pharmacokinetics | Glaucoma - physiopathology | Disease Models, Animal | Cell Line | Intraocular Pressure - physiology | Glaucoma - drug therapy | Timolol - pharmacology | Treatment Outcome | Antihypertensive Agents - pharmacokinetics | Rats, Sprague-Dawley | Animals | Prostaglandins F, Synthetic - pharmacology | Drug Combinations | Measurement | Complications and side effects | Physiological aspects | Tafluprost | Dosage and administration | Research | Intraocular pressure | Glaucoma | Cornea | Pressure effects | Laboratories | Toxicity | Epithelial cells | Cytotoxicity | Monkeys | Ophthalmology | Safety | Drug dosages | Timolol | Pharmaceutical sciences | Hypertension | Research & development--R&D | Mass spectroscopy | Liquid chromatography | Pharmacology | Bioavailability | Patients | Dilution | Acids | Pharmacokinetics | Mass spectrometry | Index Medicus | Research & development | R&D
Journal Article
Experimental Eye Research, ISSN 0014-4835, 2011, Volume 93, Issue 3, pp. 250 - 255
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0146680 - e0146680
Backgroud To assess the noninferiority of a dorzolamide-timolol fixed combination (DTFC) versus latanoprost in terms of intraocular pressure (IOP) and to... 
COSOPT | OPEN-ANGLE GLAUCOMA | TIMOLOL 0.5-PERCENT | MULTIDISCIPLINARY SCIENCES | BLOOD-PRESSURE | HEMODYNAMICS | Thiophenes - therapeutic use | Demography | Intraocular Pressure - drug effects | Thiophenes - adverse effects | Humans | Middle Aged | Systole - drug effects | Male | Heart Rate - drug effects | Female | Blood Pressure - drug effects | Diastole - drug effects | Timolol - therapeutic use | Timolol - adverse effects | Thiophenes - pharmacology | Timolol - pharmacology | Low Tension Glaucoma - drug therapy | Prostaglandins F, Synthetic - adverse effects | Prostaglandins F, Synthetic - therapeutic use | Sulfonamides - pharmacology | Latanoprost | Cross-Over Studies | Sulfonamides - therapeutic use | Perfusion | Sulfonamides - adverse effects | Prostaglandins F, Synthetic - pharmacology | Circadian Rhythm - drug effects | Low Tension Glaucoma - physiopathology | Drug Combinations | Measurement | Glaucoma | Patient outcomes | Dorzolamide | Perfusion (Physiology) | Physiological aspects | Dosage and administration | Timolol maleate | Drug therapy, Combination | Drug therapy | Intraocular pressure | Drugs | Cornea | Optic nerve | Statistical analysis | Review boards | Clinical trials | Patients | Beta blockers | Diurnal | Defects | Studies | Demographics | Randomization | Hospitals | Upper bounds | Blood pressure | Tension | Significance | Timolol | Index Medicus
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 02/2017, Volume 140, Issue 3, pp. 495 - 508
Journal Article